#prison

An outbreak has prompted a mass vaccination effort.

Abu-Jamal spent years fighting for access to hepatitis C treatment in prison.

This is one of several lawsuits filed by advocates on behalf of inmates with the liver virus in U.S. prisons.

In a recent settlement, the state agreed to expand coverage of HCV treatment—but only to those with advanced liver scarring.

The state is appealing a ruling that requires the prison system to properly treat inmates with the virus.

But doing so would place a considerable financial burden on prison budgets.

The subscription-based model is the first of its kind.

The right was secured via a class-action lawsuit settlement.

Advocates say out of some 3,000 inmates recently diagnosed with the virus, just 46 have received any sort of treatment.

Three lawsuits allege prison officials denied them treatment for more than a year, despite serious illness.

Lawsuits across the country are demanding access to treatment for incarcerated populations. Here’s why.

Existing federal law could permit prisons to negotiate a 90 percent–plus discount—without scaring off pharma.

Louisiana health officials are adopting the country’s first subscription model for hep C cures.

Researchers analyzed data resulting from a uniform hepatitis C testing policy in Washington state’s correctional facilities.

A new report shows people who inject drugs are substantially more likely to contract HIV or HCV post-incarceration.

Thus far, no state prison systems have adopted the protocols that advocates are demanding.